about
Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment.Efficacy of intravenous thrombolysis according to stroke subtypes: the Madrid Stroke Network data.Thrombolysis for ischaemic stroke and glioblastoma multiforme: a case report.Wallenberg's syndrome and symptomatic trigeminal neuralgiaViral encephalitis and atherothrombotic stroke.Intravenous thrombolytic treatment in the oldest old.Clinical practice guidelines in intracerebral haemorrhage.Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type.Guidelines for the treatment of acute ischaemic stroke.Stroke preceding autoimmune encephalitis with neuronal potassium channel antibody.Endovascular treatment of distal internal carotid artery occlusions with retrievable stents.Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.In-hospital stroke: a multi-centre prospective registry.Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style.P300 event-related potential in euthymic patients with bipolar disorder.Benefits of intravenous thrombolysis in acute ischemic stroke related to extra cranial internal carotid dissection. Dream or reality?Female gender is a factor of worse outcome in acute stroke even after thrombolytic treatment.Large artery occlusion diagnosed by computed tomography angiography in acute ischaemic stroke: frequency, predictive factors, and safety.Diabetes and previous stroke: hazards for intravenous thrombolysis?Thrombolytic Therapy for Acute Ischemic Stroke after Recent Transient Ischemic AttackInfartos cerebrales intrahospitalarios: datos del registro multicéntrico de pacientes con infarto cerebral ingresados en Cardiología y Cirugía Cardiaca[Thrombolysis in Madrid: is there improvement in the 4 years temporal analysis?]Estenosis crítica de arteria basilar asociada a inestabilidad clínica: propuesta de una nueva indicación de tratamiento endovascular agudo
P50
Q30572460-FC0F7BA3-A080-4231-9E8F-ACF523F0411BQ34320218-99DF317E-0023-45FD-8120-34ED50B4FEEEQ34530396-711C7A95-8636-48C8-92AC-CB9DF9C29C0FQ34981820-514226A9-4DC8-4D19-8605-333475892640Q35976762-3D4A4DF5-72D2-4285-8EF3-8F38D2B3B9A9Q36119123-1FDF7243-46CA-49FA-A35C-A05DCA70190AQ37875439-A92A1415-2E7A-4409-8971-4BDA15FBB75DQ37936617-A2749B3C-3877-444E-9708-8E7AA0BEB7A8Q37966157-13371AD6-3360-4BA5-B9F3-A82BA6B348D2Q42161408-6C280FE4-175F-423C-B741-63D2AAB2091AQ44260859-B05E6329-6783-4948-A37F-9A4DFBB2C9BCQ44442729-0F22401C-CFA8-4D5C-BD7C-506833E8B4DCQ48164973-F754D22C-B1F7-4FC7-B98A-36C9C299FE46Q48284695-3F83141B-DA11-4567-963F-C768B3E1F4BAQ50770876-CB3FA8B1-D4D7-45DE-9B3C-18E6133FBD07Q50998993-F3CEA27B-3A73-45BF-A9E2-4C69EF3F5046Q51439726-352002A4-6259-4B81-B5B6-575B861EE3C3Q53094066-9A8F3DB9-5625-494E-8BAD-F65B14766069Q59847096-B4724537-B95B-4306-9D9E-140FDE00D5CDQ60196899-D115029B-11D3-40B9-8C72-F1FA7C5CFBDDQ60196904-15ECF053-5638-4EA7-8519-6C5B8C93D43CQ60196911-701A6B54-B43E-4CA5-AB56-C029402B9C01Q60597010-938A1A45-5508-4565-9A52-AB460287019C
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
P Simal
@nl
Patricia Simal
@en
Patricia Simal
@es
type
label
P Simal
@nl
Patricia Simal
@en
Patricia Simal
@es
altLabel
P Simal
@en
prefLabel
P Simal
@nl
Patricia Simal
@en
Patricia Simal
@es
P106
P21
P31
P496
0000-0002-5555-5308